Baidu
map

Nat Genet:POT1基因突变与黑色素瘤相关

2014-04-07 MedSci MedSci原创

    40%的家族性黑色素瘤患者往往有CDKN2A突变;另外与黑色素瘤相关的其它一些罕见突变还包括:CDK4, BRCA2, BAP1,TERT启动子等均有关系。最新一项研究又发现端粒酶1基因保护因子(POT1)缺失,也可能是家族性恶性黑色素瘤的关键基因。    在英国,每年有近1.2万人被诊断罹患黑色素瘤。每20名黑色素瘤患者中就有1人具有明显

    40%的家族性黑色素瘤患者往往有CDKN2A突变;另外与黑色素瘤相关的其它一些罕见突变还包括:CDK4, BRCA2, BAP1,TERT启动子等均有关系。最新一项研究又发现端粒酶1基因保护因子(POT1)缺失,也可能是家族性恶性黑色素瘤的关键基因。

    在英国,每年有近1.2万人被诊断罹患黑色素瘤。每20名黑色素瘤患者中就有1人具有明显的疾病家族史。确切地找到这些患者中驱动疾病发展的遗传突变,皮肤病学家们可以此鉴别出应加入到黑色素瘤监测计划中的人群。

    该研究小组发现,携带POT1基因特异突变的人们极有可能形成黑色素瘤。这些突变导致了保护我们的染色体末端免受损伤的POT1基因失活。

    论文的共同资深作者、Wellcome Trust Sanger研究所David Adams博士说:“基因组学正处在转变健康护理系统的边缘——这一研究突显了通过基因组研究可以获得潜在临床利益,为改善患者的护理和疾病治疗提供一些 潜在的策略。利用这一研究发现,我们应该可以确定家族中的哪些成员有罹患这一疾病的风险,哪些人应该接受定期筛查实现早期检测。”

    已知的一些遗传突变导致了约40%的遗传性黑色素瘤事件。该研究小组通过对因未知突变造成遗传性黑色素瘤的184名患者的基因组进行测序,着手鉴别了导致其余60%遗传性黑色素瘤的突变。

    他们发现,这些突变引起POT1失活导致了更长并有可能不受保护的端粒。利兹大学癌症和病理学研究所所长Tim Bishop教授说:“这一研究发现大大增进了我们对于某些家庭为何具有高黑色素瘤发病率这一原因的认识。由于以往已确定了这一基因是新药开发的一个靶 点,在未来,早期检测将有可能推动更好地治疗这一疾病。”

    该研究小组还发现,还有一些其他的家族性癌症例如白血病和脑肿瘤携带这些遗传性突变。看起来失活POT1基因的突变有可能不仅是黑色素瘤,也是其他癌症的基础。

    论文的共同资深作者、利兹大学Julia Newton Bishop教授说:“我们的研究正在改变对于黑色素瘤致病原因以及最终如何预防和治疗黑色素瘤的理解,提供了一个很好的例子表明基因组学是如何改变公共 健康的。没有来自罹患这些毁灭性的、遗传性黑色素瘤家庭的帮助和包容,这一研究将无法完成。”

    该研究小组目前正在致力开发携带失活POT1基因的细胞和小鼠。未来将利用它们来检测科改变端粒代谢的潜在药物疗法。

    英国癌症研究所的科技信息沟通专员Safia Danovi说:“对于具有明显黑色素瘤家族史的人们这是重要的一步。对于我们大多数人来说,重要的是要记住避免晒伤,太阳伞是减少这一疾病风险的最好方式。”

原始出处:

Robles-Espinoza CD, Harland M, Ramsay AJ, Aoude LG, Quesada V, Ding Z, Pooley KA, Pritchard AL, Tiffen JC, Petljak M, Palmer JM, Symmons J, Johansson P, Stark MS, Gartside MG, Snowden H, Montgomery GW, Martin NG, Liu JZ, Choi J, Makowski M, Brown KM, Dunning AM, Keane TM, López-Otín C, Gruis NA, Hayward NK, Bishop DT, Newton-Bishop JA, Adams DJ.POT1 loss-of-function variants predispose to familial melanoma.Nat Genet. 2014 Mar 30. doi: 10.1038/ng.2947.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1680238, encodeId=7dc1168023813, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86707, encryptionId=9e5c86e0712, topicName=色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343027846633, createdName=sunylz, createdTime=Sat Oct 11 17:46:00 CST 2014, time=2014-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685935, encodeId=8b19168593511, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Wed Jun 18 11:46:00 CST 2014, time=2014-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733680, encodeId=fb0c1e3368043, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Sun Dec 07 15:46:00 CST 2014, time=2014-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1773125, encodeId=11df1e73125a5, content=<a href='/topic/show?id=a30e14529c3' target=_blank style='color:#2F92EE;'>#POT1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14529, encryptionId=a30e14529c3, topicName=POT1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ce838484329, createdName=zhzhxiang, createdTime=Tue Jan 13 18:46:00 CST 2015, time=2015-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048581, encodeId=01502048581ad, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sun Aug 31 10:46:00 CST 2014, time=2014-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880003, encodeId=01c21880003c4, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Jan 26 09:46:00 CST 2015, time=2015-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558654, encodeId=01b61558654ed, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Wed Apr 09 03:46:00 CST 2014, time=2014-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1564663, encodeId=470f1564663c2, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Wed Apr 09 03:46:00 CST 2014, time=2014-04-09, status=1, ipAttribution=)]
    2014-10-11 sunylz
  2. [GetPortalCommentsPageByObjectIdResponse(id=1680238, encodeId=7dc1168023813, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86707, encryptionId=9e5c86e0712, topicName=色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343027846633, createdName=sunylz, createdTime=Sat Oct 11 17:46:00 CST 2014, time=2014-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685935, encodeId=8b19168593511, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Wed Jun 18 11:46:00 CST 2014, time=2014-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733680, encodeId=fb0c1e3368043, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Sun Dec 07 15:46:00 CST 2014, time=2014-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1773125, encodeId=11df1e73125a5, content=<a href='/topic/show?id=a30e14529c3' target=_blank style='color:#2F92EE;'>#POT1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14529, encryptionId=a30e14529c3, topicName=POT1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ce838484329, createdName=zhzhxiang, createdTime=Tue Jan 13 18:46:00 CST 2015, time=2015-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048581, encodeId=01502048581ad, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sun Aug 31 10:46:00 CST 2014, time=2014-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880003, encodeId=01c21880003c4, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Jan 26 09:46:00 CST 2015, time=2015-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558654, encodeId=01b61558654ed, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Wed Apr 09 03:46:00 CST 2014, time=2014-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1564663, encodeId=470f1564663c2, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Wed Apr 09 03:46:00 CST 2014, time=2014-04-09, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1680238, encodeId=7dc1168023813, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86707, encryptionId=9e5c86e0712, topicName=色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343027846633, createdName=sunylz, createdTime=Sat Oct 11 17:46:00 CST 2014, time=2014-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685935, encodeId=8b19168593511, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Wed Jun 18 11:46:00 CST 2014, time=2014-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733680, encodeId=fb0c1e3368043, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Sun Dec 07 15:46:00 CST 2014, time=2014-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1773125, encodeId=11df1e73125a5, content=<a href='/topic/show?id=a30e14529c3' target=_blank style='color:#2F92EE;'>#POT1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14529, encryptionId=a30e14529c3, topicName=POT1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ce838484329, createdName=zhzhxiang, createdTime=Tue Jan 13 18:46:00 CST 2015, time=2015-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048581, encodeId=01502048581ad, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sun Aug 31 10:46:00 CST 2014, time=2014-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880003, encodeId=01c21880003c4, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Jan 26 09:46:00 CST 2015, time=2015-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558654, encodeId=01b61558654ed, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Wed Apr 09 03:46:00 CST 2014, time=2014-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1564663, encodeId=470f1564663c2, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Wed Apr 09 03:46:00 CST 2014, time=2014-04-09, status=1, ipAttribution=)]
    2014-12-07 canlab
  4. [GetPortalCommentsPageByObjectIdResponse(id=1680238, encodeId=7dc1168023813, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86707, encryptionId=9e5c86e0712, topicName=色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343027846633, createdName=sunylz, createdTime=Sat Oct 11 17:46:00 CST 2014, time=2014-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685935, encodeId=8b19168593511, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Wed Jun 18 11:46:00 CST 2014, time=2014-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733680, encodeId=fb0c1e3368043, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Sun Dec 07 15:46:00 CST 2014, time=2014-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1773125, encodeId=11df1e73125a5, content=<a href='/topic/show?id=a30e14529c3' target=_blank style='color:#2F92EE;'>#POT1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14529, encryptionId=a30e14529c3, topicName=POT1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ce838484329, createdName=zhzhxiang, createdTime=Tue Jan 13 18:46:00 CST 2015, time=2015-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048581, encodeId=01502048581ad, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sun Aug 31 10:46:00 CST 2014, time=2014-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880003, encodeId=01c21880003c4, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Jan 26 09:46:00 CST 2015, time=2015-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558654, encodeId=01b61558654ed, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Wed Apr 09 03:46:00 CST 2014, time=2014-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1564663, encodeId=470f1564663c2, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Wed Apr 09 03:46:00 CST 2014, time=2014-04-09, status=1, ipAttribution=)]
    2015-01-13 zhzhxiang
  5. [GetPortalCommentsPageByObjectIdResponse(id=1680238, encodeId=7dc1168023813, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86707, encryptionId=9e5c86e0712, topicName=色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343027846633, createdName=sunylz, createdTime=Sat Oct 11 17:46:00 CST 2014, time=2014-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685935, encodeId=8b19168593511, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Wed Jun 18 11:46:00 CST 2014, time=2014-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733680, encodeId=fb0c1e3368043, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Sun Dec 07 15:46:00 CST 2014, time=2014-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1773125, encodeId=11df1e73125a5, content=<a href='/topic/show?id=a30e14529c3' target=_blank style='color:#2F92EE;'>#POT1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14529, encryptionId=a30e14529c3, topicName=POT1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ce838484329, createdName=zhzhxiang, createdTime=Tue Jan 13 18:46:00 CST 2015, time=2015-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048581, encodeId=01502048581ad, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sun Aug 31 10:46:00 CST 2014, time=2014-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880003, encodeId=01c21880003c4, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Jan 26 09:46:00 CST 2015, time=2015-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558654, encodeId=01b61558654ed, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Wed Apr 09 03:46:00 CST 2014, time=2014-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1564663, encodeId=470f1564663c2, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Wed Apr 09 03:46:00 CST 2014, time=2014-04-09, status=1, ipAttribution=)]
    2014-08-31 cy0324
  6. [GetPortalCommentsPageByObjectIdResponse(id=1680238, encodeId=7dc1168023813, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86707, encryptionId=9e5c86e0712, topicName=色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343027846633, createdName=sunylz, createdTime=Sat Oct 11 17:46:00 CST 2014, time=2014-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685935, encodeId=8b19168593511, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Wed Jun 18 11:46:00 CST 2014, time=2014-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733680, encodeId=fb0c1e3368043, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Sun Dec 07 15:46:00 CST 2014, time=2014-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1773125, encodeId=11df1e73125a5, content=<a href='/topic/show?id=a30e14529c3' target=_blank style='color:#2F92EE;'>#POT1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14529, encryptionId=a30e14529c3, topicName=POT1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ce838484329, createdName=zhzhxiang, createdTime=Tue Jan 13 18:46:00 CST 2015, time=2015-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048581, encodeId=01502048581ad, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sun Aug 31 10:46:00 CST 2014, time=2014-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880003, encodeId=01c21880003c4, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Jan 26 09:46:00 CST 2015, time=2015-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558654, encodeId=01b61558654ed, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Wed Apr 09 03:46:00 CST 2014, time=2014-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1564663, encodeId=470f1564663c2, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Wed Apr 09 03:46:00 CST 2014, time=2014-04-09, status=1, ipAttribution=)]
    2015-01-26 liye789132251
  7. [GetPortalCommentsPageByObjectIdResponse(id=1680238, encodeId=7dc1168023813, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86707, encryptionId=9e5c86e0712, topicName=色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343027846633, createdName=sunylz, createdTime=Sat Oct 11 17:46:00 CST 2014, time=2014-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685935, encodeId=8b19168593511, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Wed Jun 18 11:46:00 CST 2014, time=2014-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733680, encodeId=fb0c1e3368043, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Sun Dec 07 15:46:00 CST 2014, time=2014-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1773125, encodeId=11df1e73125a5, content=<a href='/topic/show?id=a30e14529c3' target=_blank style='color:#2F92EE;'>#POT1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14529, encryptionId=a30e14529c3, topicName=POT1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ce838484329, createdName=zhzhxiang, createdTime=Tue Jan 13 18:46:00 CST 2015, time=2015-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048581, encodeId=01502048581ad, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sun Aug 31 10:46:00 CST 2014, time=2014-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880003, encodeId=01c21880003c4, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Jan 26 09:46:00 CST 2015, time=2015-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558654, encodeId=01b61558654ed, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Wed Apr 09 03:46:00 CST 2014, time=2014-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1564663, encodeId=470f1564663c2, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Wed Apr 09 03:46:00 CST 2014, time=2014-04-09, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=1680238, encodeId=7dc1168023813, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86707, encryptionId=9e5c86e0712, topicName=色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343027846633, createdName=sunylz, createdTime=Sat Oct 11 17:46:00 CST 2014, time=2014-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685935, encodeId=8b19168593511, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Wed Jun 18 11:46:00 CST 2014, time=2014-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733680, encodeId=fb0c1e3368043, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Sun Dec 07 15:46:00 CST 2014, time=2014-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1773125, encodeId=11df1e73125a5, content=<a href='/topic/show?id=a30e14529c3' target=_blank style='color:#2F92EE;'>#POT1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14529, encryptionId=a30e14529c3, topicName=POT1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ce838484329, createdName=zhzhxiang, createdTime=Tue Jan 13 18:46:00 CST 2015, time=2015-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048581, encodeId=01502048581ad, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sun Aug 31 10:46:00 CST 2014, time=2014-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880003, encodeId=01c21880003c4, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Jan 26 09:46:00 CST 2015, time=2015-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558654, encodeId=01b61558654ed, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Wed Apr 09 03:46:00 CST 2014, time=2014-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1564663, encodeId=470f1564663c2, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Wed Apr 09 03:46:00 CST 2014, time=2014-04-09, status=1, ipAttribution=)]

相关资讯

Nat Genet:发现皮肤癌风险基因

研究人员发现一种特异的基因发生突变可导致遗传性黑色素瘤。 在英国,每年有近1.2万人被诊断罹患黑色素瘤。每20名黑色素瘤患者中就有1人具有明显的疾病家族史。确切地找到这些患者中驱动疾病发展的遗传突变,皮肤病学家们可以此鉴别出应加入到黑色素瘤监测计划中的人群。 该研究小组发现,携带POT1基因特异突变的人们极有可能形成黑色素瘤。这些突变导致了保护我们的染色体末端免

STM:迫使癌细胞自我消化

当癌细胞不再自我降解的时候,癌症就产生了。瑞士伯尔尼科学家以皮肤癌为模型,发现了一个在癌细胞降解过程中发挥重要作用的蛋白质。通过治疗性的重新激活该降解过程,就能迫使癌细胞自我吞噬。 细胞能够降解破坏的分子也能够该通过自噬过程降解整个细胞器,降解的分子还能够当做原料产生新的分子或细胞器。该细胞自我消化过程称之为自噬,可以认为是一种细胞自我修复的过程。 自噬产生的能量对细胞在缺少养料,氧气或生

IJC:阻止谷氨酸盐摄入能抑制黑色素瘤生长

  根据位于悉尼的世纪研究所(Centenary Institute)(www.centenary.org.au)和悉尼大学(The University of Sydney)的最新研究,澳大利亚的科研人员认为可以通过切断其食物来源治疗黑色素瘤——通过饿死癌细胞以控制黑色素瘤。   研究人员们在2013年发现可以“饿死”前列腺癌,现在这一进一步的发现为治疗包括黑色素瘤在内的一系列癌症

Lancet Oncol:威罗非尼改善BRAF突变黑色素瘤患者生存

BRAF V600突变阳性的转移性黑色素瘤,该病是一种致命的,具有危险性的皮肤癌。BRIM-3试验旨在研究威罗非尼(vemurafenib)改善BRAF突变黑色素瘤患者生存率。BRIM-3是一项多中心Ⅲ期随机开放研究,纳入来自12个国家、104个中心、未经治疗的675例BRAFV 600突变阳性的转移性黑色素瘤患者。延长随访时间的分析结果显示,与达卡巴嗪组相比,威罗非尼(vemurafen

Lancet Oncol:Vemurafenib治疗黑色素瘤安全有效

研究要点:转移性黑色素瘤的预后很差,化疗的治疗作用有限, 联合应用细胞生长抑制药物和细胞因子并不会改善患者的生存期;RAS-RAF-MEK-ERK MAPK旁路是驱动细胞转变为恶性黑色素瘤细胞的主要动力,因此患者可从BRAF抑制治疗中得到的获益;在黑色素瘤患者中,无论其存在的是最常见的BRAFV600E突变还是最少见的BRAFV600K突变,应用vemurafenib针对BRAF进行抑制都能显

默沙东向FDA提交黑色素瘤药物MK-3475的上市申请

默沙东已启动向FDA提交皮肤癌新药MK-3475的上市申请,并表示可能于今年上半年完成申报。MK-3475已被FDA授予突破性治疗药物资格,所以其有资格进行快速审评,这意味着如果审评过程一切顺利的话,那该药物可能会在今年底即获得批准。MK-3475是一款抗PD1药物,该类药物包括百时美施贵宝的Nivolumab以及罗氏的MPDL3280A。在去年11月份报道的一项Ib期临床研究中,MK-3475已

Baidu
map
Baidu
map
Baidu
map